Safety and efficacy of MRI-guided transurethral ultrasound ablation for radiorecurrent prostate cancer in the presence of gold fiducial markers.

Pietari Mäkelä Cameron WrightMikael AnttinenPeter J BoströmRoberto Blanco Sequeiros

Published in: Acta radiologica (Stockholm, Sweden : 1987) (2022)

Patients with radiorecurrent PCa with intraprostatic gold fiducial markers can be successfully treated with TULSA. The early-stage efficacy of sTULSA for patients with intraprostatic gold markers is encouraging and the safety profile is unaffected by marker presence.

Keyphrases

prostate cancer
early stage
magnetic resonance imaging
radical prostatectomy
contrast enhanced
squamous cell carcinoma
computed tomography
magnetic resonance
sentinel lymph node
diffusion weighted imaging
neoadjuvant chemotherapy